Citation Information :
Pais ML, D Souza RC, Surlu VR, Boloor R, Baliga MS, Jakribettu RP. Changing trend in the clinico-bacteriological profile of diabetic foot infection over a decade: observations from a tertiary care hospital of India. 2023; 25 (1):24-28.
BACKGROUND: Diabetic foot infection (DFI) is a major challenge in podiatric surgery. Initiation of an appropriate antimicrobial drug is the determining factor in the prognosis in DFI.
AIM: This study was undertaken to analyse the changing trends in the clinical profile of patients and the bacterial profile causing DFI for over a decade.
MATERIALS AND METHODS: This was a retrospective observational study conducted at the department of microbiology and surgery of the tertiary teaching hospital. The clinical and bacterial profile of patients with DFI in 2009 and 2019 was collected and analysed for the changing trend.
RESULTS: Amongst the 203 patients (95 in 2009 and 108 in 2019) included in the study, 113 (56%) were male patients. There was a shift in the age group of patients from 51–60 to 61–70 years over a decade. There was a change of most common pathogens from Pseudomonas aeruginosa to Klebsiella species. The resistance rates to third-generation cephalosporins decreased amongst the Gram-negative isolates such as P. aeruginosa and Escherichia coli, but an increase in resistance to carbapenems was observed during the study period. There was reduced incidence of infection with methicillin-resistant Staphylococcus aureus during the study period.
CONCLUSION: There was a change in the demographic and bacteriological flora in the DFI patients over a decade. The antimicrobial resistance rate varied for various antimicrobial agents over a decade for a particular pathogen. Regular surveillance of the change in resistance pattern amongst the pathogens is essential for the initiation of appropriate empirical therapy to reduce the morbidity in DFI.
World Health Organization. Antimicrobial Resistance: Global Report on Surveillance. Geneva: World Health Organization; 2014.
World Health Organization. Monitoring and Evaluation of the Global Action Plan on Antimicrobial Resistance: Framework and Recommended Indicators. Geneva: World Health Organization; 2019.
Kaveeshwar SA, Cornwall J. The current state of diabetes mellitus in India. Australas Med J 2014;7:45-8.
Dietrich I, Braga GA, de Melo FG, da Costa Silva Silva AC. The diabetic foot as a proxy for cardiovascular events and mortality review. Curr Atheroscler Rep 2017;19:44.
Thiruvoipati T, Kielhorn CE, Armstrong EJ. Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes. World J Diabetes 2015;6:961-9.
Lipsky BA. Diabetic foot infections: Current treatment and delaying the ‘post-antibiotic era’. Diabetes Metab Res Rev 2016;32 Suppl 1:246-53.
Frykberg RG. Diabetic foot ulcers: Pathogenesis and management. Am Fam Physician 2002;66:1655-62.
Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 19th ed. CLSI supplement M100. Clinical and Laboratory Standards Institute, USA, 2009.
Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. CLSI Supplement M100. 29th ed. USA: Clinical and Laboratory Standards Institute; 2019.
Saseedharan S, Sahu M, Chaddha R, Pathrose E, Bal A, Bhalekar P, et al. Epidemiology of diabetic foot infections in a reference tertiary hospital in India. Braz J Microbiol 2018;49:401-6.
Chai W, Wang Y, Zheng H, Yue S, Liu Y, Wu Y, et al. The profile of microbiological pathogens in diabetic foot ulcers. Front Med (Lausanne) 2021;8:656467.
Seth A, Attri AK, Kataria H, Kochhar S, Seth SA, Gautam N. Clinical profile and outcome in patients of diabetic foot infection. Int J Appl Basic Med Res 2019;9:14-9.
Ahmadishooli A, Davoodian P, Shoja S, Ahmadishooli B, Dadvand H, Hamadiyan H, et al. Frequency and antimicrobial susceptibility patterns of diabetic foot infection of patients from Bandar Abbas district, Southern Iran. J Pathog 2020;2020:1057167.
Honda Y, Wakabayashi K, Sato C, Ikeda N, Sato K, Suzuki T, et al. Chronic kidney disease is a key predictive factor for potential myocardial ischaemia and poor prognosis in asymptomatic patients with diabetes mellitus. Sci Rep 2022;12:10268.
Shah P, Inturi R, Anne D, Jadhav D, Viswambharan V, Khadilkar R, et al. Wagner's classification as a tool for treating diabetic foot ulcers: Our observations at a suburban teaching hospital. Cureus 2022;14:e21501.
Rampal SR, Devaraj NK, Yoganathan PR, Mahusin MA, Teh SW, Kumar SS. Distribution and prevalence of microorganisms causing diabetic foot infection in hospital Serdang and hospital Ampang for the year 2010 to 2014. Biocatal Agric Biotechnol 2019;17:256-60.
Lipsky BA, Aragón-Sánchez J, Diggle M, Embil J, Kono S, Lavery L, et al. IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev 2016;32 Suppl 1:45-74.
Lee JS, Son ST, Han SK. Risk factors of methicillin-resistant Staphylococcus aureus and Pseudomonas infection in diabetic foot ulcers in Korea. J Wound Manage Res 2017;13:29-34.
Kwon KT, Armstrong DG. Microbiology and antimicrobial therapy for diabetic foot infections. Infect Chemother 2018;50:11-20.